In summary, these findings highlight the complex roles of CAPG and DDAH2 in modulating immune cell functions in both T2DM and sepsis, suggesting that targeting these proteins may offer potential therapeutic strategies for managing inflammation and immune dysregulation in these diseases. The gene discussed is CAPG; the disease is type 2 diabetes mellitus.